Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age.

Esposito S, Lizioli A, Lastrico A, Begliatti E, Rognoni A, Tagliabue C, Cesati L, Carreri V, Principi N.

Respir Res. 2007 Feb 21;8:12.

2.

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.

Black SB, Shinefield HR, Ling S, Hansen J, Fireman B, Spring D, Noyes J, Lewis E, Ray P, Lee J, Hackell J.

Pediatr Infect Dis J. 2002 Sep;21(9):810-5.

PMID:
12352800
3.

Impact of the pneumococcal conjugate vaccine on otitis media.

Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P.

Pediatr Infect Dis J. 2003 Jan;22(1):10-6. Erratum in: Pediatr Infect Dis J. 2003 Feb;22(2):163.

PMID:
12544402
4.

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection.

Nachman S, Kim S, King J, Abrams EJ, Margolis D, Petru A, Shearer W, Smith E, Moye J, Blanchard S, Hawkins E, Bouquin P, Vink P, Benson M, Estep S, Malinoski F; Pediatric AIDS Clinical Trials Group Study 292 Team..

Pediatrics. 2003 Jul;112(1 Pt 1):66-73.

PMID:
12837869
5.

Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine.

Garbutt J, Rosenbloom I, Wu J, Storch GA.

Pediatrics. 2006 Jun;117(6):e1087-94.

PMID:
16740811
6.

Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age.

Käyhty H, Ahman H, Eriksson K, Sörberg M, Nilsson L.

Pediatr Infect Dis J. 2005 Feb;24(2):108-14.

PMID:
15702037
7.

Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine.

Poehling KA, Szilagyi PG, Grijalva CG, Martin SW, LaFleur B, Mitchel E, Barth RD, Nuorti JP, Griffin MR.

Pediatrics. 2007 Apr;119(4):707-15. Erratum in: Pediatrics. 2007 Jun;119(6):1270.

PMID:
17403841
8.

Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media.

Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, Keegan E.

Pediatr Infect Dis J. 2004 Sep;23(9):829-33.

PMID:
15361721
9.

Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy.

Boccalini S, Azzari C, Resti M, Valleriani C, Cortimiglia M, Tiscione E, Bechini A, Bonanni P.

Vaccine. 2011 Nov 28;29(51):9521-8. doi: 10.1016/j.vaccine.2011.10.013. Epub 2011 Oct 18.

PMID:
22008820
11.

[The safety and immunogenicity of an heptavalent pneumococcal polysaccharide conjugate vaccine (Prevenar) administered in association with a whole-cell pertussis-based pediatric combination vaccine (DTP-IPV/PRP-T) to French infants with a two-, three-, and four-month schedule].

Reinert P, Guy M, Girier B, Szelechowski B, Baudoin B, Deberdt P, Wollner A, Kemeny G, Amzallag M, Moat C, Szelechowski C, Villain-Lemoine H, Bouhanna CA, Laudat F.

Arch Pediatr. 2003 Dec;10(12):1048-55. French.

PMID:
14643532
12.

Effectiveness of pneumococcal conjugate vaccine in infants by maternal influenza vaccination status.

van Santen KL, Bednarczyk RA, Adjaye-Gbewonyo D, Orenstein WA, Davis R, Omer SB.

Pediatr Infect Dis J. 2013 Nov;32(11):1180-4. doi: 10.1097/INF.0b013e3182a26752.

PMID:
23856786
13.

Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.

Cohen R, Levy C, de La Rocque F, Gelbert N, Wollner A, Fritzell B, Bonnet E, Tetelboum R, Varon E.

Pediatr Infect Dis J. 2006 Nov;25(11):1001-7.

PMID:
17072121
14.

Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers.

Dagan R, Givon-Lavi N, Zamir O, Fraser D.

Pediatr Infect Dis J. 2003 Jun;22(6):532-40.

PMID:
12799510
15.

Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infants.

Lin ND, Kleinman K, Chan KA, Yu XJ, France EK, Xu S, Wei F, Mullooly J, Santoli J, Lieu TA; Vaccine Safety Datalink Group..

BMC Pediatr. 2005 Nov 28;5:43.

17.

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants.

Zangwill KM, Greenberg DP, Chiu CY, Mendelman P, Wong VK, Chang SJ, Partridge S, Ward JI.

Vaccine. 2003 May 16;21(17-18):1894-900.

PMID:
12706674
18.

Theoretic coverage of heptavalent pneumococcal conjugate vaccine in the prevention of community-acquired pneumonia in children in Italy.

Esposito S, Madore DV, Gironi S, Bosis S, Tosi S, Bianchi C, Cimino C, Principi N.

Vaccine. 2003 Jun 20;21(21-22):2704-7.

PMID:
12798607
19.

Pneumococcal conjugate vaccine for young children.

Selman S, Hayes D, Perin LA, Hayes WS.

Manag Care. 2000 Sep;9(9):49-52, 54, 56-7 passim. Review.

20.

Supplemental Content

Support Center